🍽🦠 PubMed Studies Citing Bacteria Shifts for Bacillus amyloliquefaciens group {B. Amyloliquefaciens} - Lactobacillaceae

Citations are updated once a week. Recently added citations may not appear.

6 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Bacillus amyloliquefaciens group {B. Amyloliquefaciens} - Lactobacillaceae    👪 Effects of dietary <i>Bacillus amyloliquefaciens</i> supplementation on growth performance, intestinal morphology, inflammatory response, and microbiota of intra-uterine growth retarded weanling piglets.
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 9 Issue Pages: 22
Pub: 2018 Epub: 2018 Mar 13 Authors Li Y , Zhang H , Su W , Ying Z , Chen Y , Zhang L , Lu Z , Wang T ,
Html Article Publication
Bacillus amyloliquefaciens group {B. Amyloliquefaciens} - Lactobacillaceae    📓 Bacillus amyloliquefaciens 40 regulates piglet performance, antioxidant capacity, immune status and gut microbiota.
Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 12 Issue Pages: 116-127
Pub: 2023 Mar Epub: 2022 Oct 1 Authors Jiang Z , Su W , Li W , Wen C , Du S , He H , Zhang Y , Gong T , Wang X , Wang Y , Jin M , Lu Z ,
Html Article Publication
Bacillus amyloliquefaciens group {B. Amyloliquefaciens} - Lactobacillaceae    📓 The Effects of Dietary Bacillus amyloliquefaciens TL106 Supplementation, as an Alternative to Antibiotics, on Growth Performance, Intestinal Immunity, Epithelial Barrier Integrity, and Intestinal Microbiota in Broilers.
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 12 Issue 22 Pages:
Pub: 2022 Nov 9 Epub: 2022 Nov 9 Authors Bao C , Zhang W , Wang J , Liu Y , Cao H , Li F , Liu S , Shang Z , Cao Y , Dong B ,
Html Article Publication
Bacillus amyloliquefaciens group {B. Amyloliquefaciens} - Lactobacillaceae    📓 Bacillus amyloliquefaciens SC06 alleviates the obesity of ob/ob mice and improves their intestinal microbiota and bile acid metabolism.
Food & function (Food Funct ) Vol: 13 Issue 9 Pages: 5381-5395
Pub: 2022 May 10 Epub: 2022 May 10 Authors Zeng Z , Zhou Y , Xu Y , Wang S , Wang B , Zeng Z , Wang Q , Ye X , Jin L , Yue M , Tang L , Zou P , Zhao P , Li W ,
Publication
Bacillus amyloliquefaciens group {B. Amyloliquefaciens} - Lactobacillaceae    📓 Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
Journal of applied microbiology (J Appl Microbiol ) Vol: 131 Issue 1 Pages: 470-484
Pub: 2021 Jul Epub: 2020 Dec 18 Authors Bao CL , Liu SZ , Shang ZD , Liu YJ , Wang J , Zhang WX , Dong B , Cao YH ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)